iShares LifePath Target Date 2065 ETF (NYSEARCA:ITDI) Trading Down 1.2% – Should You Sell?

iShares LifePath Target Date 2065 ETF (NYSEARCA:ITDIGet Free Report) were down 1.2% during mid-day trading on Thursday . The stock traded as low as $41.42 and last traded at $41.42. Approximately 626 shares changed hands during mid-day trading, a decline of 86% from the average session volume of 4,337 shares. The stock had previously closed at $41.92.

iShares LifePath Target Date 2065 ETF Stock Down 1.2%

The stock has a market capitalization of $26.51 million, a PE ratio of 20.19 and a beta of 0.89. The stock has a fifty day moving average of $41.81 and a 200-day moving average of $39.90.

Hedge Funds Weigh In On iShares LifePath Target Date 2065 ETF

An institutional investor recently bought a new position in iShares LifePath Target Date 2065 ETF stock. Orion Porfolio Solutions LLC acquired a new position in shares of iShares LifePath Target Date 2065 ETF (NYSEARCA:ITDIFree Report) in the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund acquired 12,554 shares of the company’s stock, valued at approximately $465,000. Orion Porfolio Solutions LLC owned approximately 2.85% of iShares LifePath Target Date 2065 ETF as of its most recent filing with the Securities & Exchange Commission.

iShares LifePath Target Date 2065 ETF Company Profile

(Get Free Report)

The iShares LifePath Target Date 2065 ETF (ITDI) is an exchange-traded fund that mostly invests in target date asset allocation. The fund is an actively managed fund-of-funds that invests in equity, fixed income, and money market ETFs using an asset allocation strategy that shifts exposure as the target retirement date approaches. The fund is intended for investors who anticipate retiring around 2065 ITDI was launched on Oct 17, 2023 and is issued by BlackRock.

Further Reading

Receive News & Ratings for iShares LifePath Target Date 2065 ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iShares LifePath Target Date 2065 ETF and related companies with MarketBeat.com's FREE daily email newsletter.